substitutions/site/month). Following seroconversion, there was a striking increase in viral diversity. Most seroconverters had viral variants that showed evidence of positive selection, which was seen mainly postseroconversion. Conclusions: The high viral diversity before a reduction in HBV DNA and before HBeAg seroconversion, could either be related to occurrence of stochastic mutations that lead to a break in immune tolerance, or increased immune reactivity that drives escape mutations. In a follow-up study, we examined the long term evolution of HBV quasispecies and whether the increase in viral diversity could be confirmed. Furthermore, we sought to determine if this increase in viral diversity could result in creation of new CpG motifs, which could stimulate Toll Receptor 9. TLR9 is one member of a family of highly conserved molecular pattern recognition receptors-toll like receptors, and is stimulated by unmethylated CpG dinucleotides resulting in activation of the innate immune response and consequently adaptive immune response. In this study, we analyzed if there were any CpG sites in the HBV genome of chronic hepatitis B patients and their relationship with HBeAg seroconversion, using Eight HBeAg seroconverters followed up 6-10 years before seroconversion were included. Serum samples of 5 to 9 time points before HBeAg seroconversion were used in the study. Seven non-seroconverters with matching follow up period and stored serum samples were involved as controls. An identical methodology was used to evaluate 20 clones per serum sample and analysed using the same methodology as previously. HBV CpGs status was analyzed with the sequence alignments. Results: The HBV quasispecies viral diversity gradually increased from 1.4×10 -3 to 1.2×10 -2 within 9 years before HBeAg seroconversion. Positive selection was detected in 5 of 8 seroconverters in the study period. New CpG motifs also emerged before HBeAg seroconversion. The increase of viral diversity was closely correlated with the reduction of HBV DNA, HBeAg levels and increase in frequency of precore stop codon mutation.
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Conclusion:
The gradual increase of HBV quasispecies over time before HBeAg seroconversion could be related to accumulation of stochastic mutations which result in occurrence of new CpG motifs that activated the innate immune response and break the immune tolerance leading to HBeAg seroconversion. 
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CS1-04 Gender and HBV -Interaction between Human Sex Hormones and HBV Transcription/Replication
Pei-Jer Chen *. National Taiwan University and Hospital, Taipei, Taiwan
One interesting outcome of chronic hepatitis B virus infection has been a more common development of end-stage liver diseases in males than females. This gender disparity is more striking in HBV-related liver cancer, in which male patients usually outnumber females to 5-7 folds. The hypothesis is proposed either males more vulnerable to HBV-carcinogenesis or females more protective against this process, or both. The hypothesis has been supported by epidemiological investigations in which higher androgen levels are correlated with more risk of HCC in male carriers, and use of estrogen supplements reduces HCC in female carriers. Now we present the results how human sex hormones axis interacts with HBV. It was found that androgen receptor could bind directly to HBV genome, via enhancer I, to augment HBV transcription and replication. Besides, androgen receptor can cooperate with HBV X protein to enhance downstream cancer-promoting pathway. In contrast, there are data indicating female estrogen receptor able to down regulate HBV gene transcription, maybe via a remodeling of viral genome. The addition of estrogen to male HBV transgenic mice could reduce HBV titers. These results may explain the mechanisms for a male susceptibility to HBV-related end stage liver diseases and might point out directions to anti-viral targets. Streptococcus suis is a Gram-positive coccus, causing meningitis, septicaemia, pneumonia, and purulent arthritisis in pigs. Human infection is acquired through exposure to colonized pigs or contaminated pig meat. Infection is likely to occur through direct contact, e.g. through skin lesions during butchering, but other routes of infection, such as gastro-intestinal, cannot be excluded. In the past few years the number of reported S. suis infections in humans has increased significantly, with most cases originating in Southeast Asia where there exists a high density of pig farming. Increased awareness, improved diagnostics and the occurrence of outbreaks have contributed to this increase. Meningitis and sepsis are the most common clinical manifestation of human S. suis infection. In Vietnam, S. suis is the most common cause of acute bacterial meningitis in adults. Infections in children are extremely rare. Meningitis is frequently complicated by sensineural hearing loss. Adjuvant treatment with dexamethasone is associated with protection against the hearing loss in S. suis meningitis. S. suis is sensitive to penicillin, although in very rare cases penicillin resistance has been reported, but high rates of resistance to tetracycline and erythromycine have been reported from human and pig isolates worldwide. Group A streptococci (GAS) are one of the most common human pathogens that cause both invasive and noninvasive infections. GAS associated diseases are more common in children than adults and clinical presentation ranges from pharyngitis and impetigo to invasive infections particularly acute rheumatic fever and acute glomerulonephritis. The M protein is an important virulence determinant in GAS which is determined by the emm gene. Currently, more than 170 emm types and 750 emm subtypes of group A streptococci have been described. Studies of GAS emm typing distribution performed worldwide, have shown a differing distribution of emm types in different countries and regions SAgs are thought to contribute to the pathogenesis of severe GAS infections by virtue of their potent immunostimulatory activity and the distribution of profiles of genes encoding SAgs has been used as an additional epidemiological tool to explore the genomic heterogeneity and possible correlation between toxin gene content and disease type. Since the late 1990s, resistance to macrolides has been increasingly detected in S. pyogenes in several European countries and other parts of the world such as Korea. There are two primary phenotypes of macrolide resistance in S. pyogenes: the M phenotype mediated by the mef genes and the MLSB phenotype mediated by the ermB genes. The latter phenotype can be constitutive, generally mediated by the ermB gene, or inducible, generally mediated by the ermA subclass TR (ermA) gene. Many studies have presented evidence that the phenotypes and R genes of S. pyogenes have changed over time.
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We analyzed the emm type and detected the susceptibilities of antibiotics to these strains and their phenotype of macrolide resistance. We also investigated the virulence factors including the superantigens of the strains. Here, we will report that there were high resistance rates against macrolides in GAS isolates collected from Chinese pharyngitis and scarlet fever patients and that the R-gene was mainly the ermB gene. We also found that the pattern of the emm-type distribution of GAS strains from Chinese pediatric patients changed with time and there is a change in the antimicrobial susceptibility and distribution of the R-gene in a large collection of between E. faecium strains during filter mating. Two of the plasmids, pZB18 (67 kbp) and pZB22 (200 kbp), were highly conjugative and were able to transfer at high frequencies of around 10-4 and
